31. Randhir R, Ms YL, Shetty K. Phenolics, their antioxidant and antimicrobial activity in dark germinated fenugreek sprouts in response to peptide and phytochemical elicitors.
32. Fahey JW, Haristoy X, Dolan PM, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.
33. Galan M V, Kishan AA, Silverman ANNL. Oral broccoli sprouts for the treatment of helicobacter pylori infection: A preliminary report. 2004; 49: 1088–1090.
34. Bahadoran Z, Tohidi M, Nazeri P, et al. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: A randomized double-blind clinical trial.
35. Boddupalli S, Mein JR, Lakkanna S, James DR. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: Perspectives in maintaining the antioxidant activity of vitamins a, C, and e.
36. Mishra C, Singh B, Singh S, et al. Role of phytochemicals in diabetes lipotoxicity: an overview. 4(4): 1604–1610.
37. Firdous SM. Guest Editorial: phytochemicals for treatment of diabetes.
38. Heather Hausenblas. Resveratrol in diabetes care.
39. Axelsson AS, Tubbs E, Mecham B, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.
40. Son MJ, Miura Y, Yagasaki K. Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice.
41. Bansode T, Salalkar B, Dighe P, et al. Comparative evaluation of antidiabetic potential of partially purified bioactive fractions from four medicinal plants in alloxan-induced diabetic rats.
42. Gebel E. Resveratrol: A Miracle Molecule?
43. Gonzalez-Abuin N, Pinent M, Casanova-Marti A, et al. Procyanidins and their healthy protective effects against type 2 diabetes.
44. Turrini E, Ferruzzi L, Fimognari C. Possible effects of dietary anthocyanins on diabetes and insulin resistance.
45. Khan N, Mukhtar H. Tea polyphenols in promotion of human health.
46. Sluijs I, Cadier E, Beulens JWJ, et al. Dietary intake of carotenoids and risk of type 2 diabetes.
47. Roohbakhsh A, Karimi G, Iranshahi M. Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review.
48. Guo H, Ling W. The update of anthocyanins on obesity and type 2 diabetes: Experimental evidence and clinical perspectives.
49. Fabricio G, Malta A, Chango A, De Freitas Mathias PC. Environmental contaminants and pancreatic beta-cells.
50. Yokoi K, Konomi A. Toxicity of so-called edible hijiki seaweed (Sargassum fusiforme) containing inorganic arsenic.
51. Mania M, Rebeniak M, Szynal T, et al. Total and inorganic arsenic in fish, seafood and seaweeds – exposure assessment.
52. Nachman KE, Ginsberg GL, Miller MD, Murray CJ, Nigra AE, Pendergrast CB. Mitigating dietary arsenic exposure: Current status in the United States and recommendations for an improved path forward.
53. Cubadda F, Jackson BP, Cottingham KL, et al. Human exposure to dietary inorganic arsenic and other arsenic species: State of knowledge, gaps and uncertainties.
54. Smith-Spangler C, Brandeau ML, Hunter GE, et al. are organic foods safer or healthier than conventional alternatives?
55. Mie A, Andersen HR, Gunnarsson S, et al. Human health implications of organic food and organic agriculture: A comprehensive review.
56. Hurtado-Barroso S, Tresserra-Rimbau A, Vallverdú-Queralt A, Lamuela-Raventós RM. Organic food and the impact on human health.